New York, December 27, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a trailblazing clinical-stage biotechnology company, has announced encouraging news from the Paul-Ehrlich-Institut (PEI), part of the Committee for Medicinal Products for Human Use (CHMP). This announcement marks a significant step forward in the company’s development of novel LAG-3 immunotherapies for cancer and autoimmune diseases. Immutep Limited Marc … Continue reading “Immutep Advances Towards Phase III Trial for Lung Cancer Treatment with Positive Regulatory Feedback”
Breaking News
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Acquires Parabola Mgmt., LLC
Acquisition Completes and Establishes Key Revenue Drivers COSTA MESA, CA, December 27, 2023 – Rodedawg…
SPZI: $53.4 million fully executed commodity contract closed
JP Energy Global, a wholly owned subsidiary of JP 3E Holdings, Inc., formerly Spooz Inc.,…
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System…
PRISM MediaWire – Weekly Press Resume – Dec. 18 to Dec. 22, 2023
New York, December 22, 2023 PRISM MediaWire – Weekly Press Resume Dec. 18 to Dec.…
HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment
New York, December 22, 2023 – Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK),…
PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%
New York, December 22, 2023 – PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting…
PRISM Analysis: Why Did CareCloud Shares Jump This Week?
New York, December 22, 2023 – Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump…
Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start
New York, December 21, 2023 – In two weeks, 2023 will be history so consider…
Palatin Technologies Sells Vyleesi in $171M Transaction
New York, December 21, 2023 – Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to…
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange
Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30…
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial
New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct…
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
LOS ANGELES, December 21, 2023 – Clubhouse Media Group, Inc. (OTC: CMGR) (“CMGR”), a social…
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%
New York, December 20, 2023 – PRISM MarketView, a leading provider of unbiased market insight…